Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy

Table 3 Results of hepatitis B virus reactivation in patients with hepatocellular carcinoma receiving local ablation therapy

Ref.	No of patients	Therapy	HBV reactivation (hepatitis)1	Morbidity/mortality
Jang et al[7]	43	7 with PEIT and 36 with RFA	0% vs 9.1% in patients with low and high viremia, respectively	None of the patients developed hepatic decompensation
Yoshida et al[39]	104	RFA	(5.6%)	Not specified
Dan et al[38]	125	RFA	5.6%	None of the patients developed hepatic failure

¹The rates of hepatitis B virus (HBV) reactivation were the frequencies in antiviral-untreated patients. RFA: Radiofrequency ablation.